Oxidized LDL, LOX-1 and atherosclerosis
- PMID: 21947818
- DOI: 10.1007/s10557-011-6341-5
Oxidized LDL, LOX-1 and atherosclerosis
Abstract
An elevated level of low density lipoprotein (LDL) cholesterol constitutes a major risk factor for genesis of atherosclerosis. Ox-LDL plays a more important role in the genesis and progression of atherosclerosis than the native LDL. Ox-LDL leads to endothelial dysfunction leading to expression of adhesion molecules and recruitment of monocyte in subendothelial space. Ox-LDL is taken up by macrophages via scavenger receptors, such as SR-A1, SR-A2 and LOX-1. Lately, LOX-1, a type II membrane protein receptor of ox-LDL, has gained much importance in relation to effects of ox-LDL on endothelial biology. Endothelial cells primarily express LOX-1 as receptor for ox-LDL and ox-LDL has been shown to upregulate expression of LOX-1. In addition, ox-LDL promotes the growth and migration of smooth muscle cells, monocytes/macrophages and fibroblasts. In this review we discuss the role of ox-LDL and LOX-1 in genesis and progression of atherosclerosis.
Similar articles
-
Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.Am J Med Sci. 2011 Aug;342(2):135-42. doi: 10.1097/MAJ.0b013e318224a147. Am J Med Sci. 2011. PMID: 21747278 Review.
-
Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis.Antioxid Redox Signal. 2011 Oct 15;15(8):2301-33. doi: 10.1089/ars.2010.3792. Epub 2011 May 25. Antioxid Redox Signal. 2011. PMID: 21338316 Review.
-
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.Can J Cardiol. 2004 Aug;20 Suppl B:32B-36B. Can J Cardiol. 2004. PMID: 15309203 Review.
-
Role of Ox-LDL and LOX-1 in Atherogenesis.Curr Med Chem. 2019;26(9):1693-1700. doi: 10.2174/0929867325666180508100950. Curr Med Chem. 2019. PMID: 29737246 Review.
-
LOX-1 and obesity.Cardiovasc Drugs Ther. 2011 Oct;25(5):469-76. doi: 10.1007/s10557-011-6335-3. Cardiovasc Drugs Ther. 2011. PMID: 21881850 Review.
Cited by
-
Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1.FASEB J. 2013 Mar;27(3):1254-63. doi: 10.1096/fj.12-222216. Epub 2012 Dec 10. FASEB J. 2013. PMID: 23230281 Free PMC article. Clinical Trial.
-
Retracted Article: LncRNA OIP5-AS1 contributes to ox-LDL-induced inflammation and oxidative stress through regulating the miR-128-3p/CDKN2A axis in macrophages.RSC Adv. 2019 Dec 17;9(71):41709-41719. doi: 10.1039/c9ra08322g. eCollection 2019 Dec 13. RSC Adv. 2019. Retraction in: RSC Adv. 2021 Jan 28;11(9):5241. doi: 10.1039/d1ra90042k. PMID: 35541591 Free PMC article. Retracted.
-
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids.Front Pharmacol. 2024 Apr 2;15:1358256. doi: 10.3389/fphar.2024.1358256. eCollection 2024. Front Pharmacol. 2024. PMID: 38628644 Free PMC article. Review.
-
Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia.Biomed Res Int. 2014;2014:353616. doi: 10.1155/2014/353616. Epub 2014 Jul 6. Biomed Res Int. 2014. PMID: 25110674 Free PMC article. Review.
-
Effects of curcumin on low-density lipoprotein oxidation: From experimental studies to clinical practice.EXCLI J. 2022 Jun 22;21:840-851. doi: 10.17179/excli2022-4878. eCollection 2022. EXCLI J. 2022. PMID: 36110563 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials